Arthur T. Sands's most recent trade in Nurix Therapeutics Inc was a trade of 450,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Feb. 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Nurix Therapeutics Inc | Arthur T. Sands | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2025 | 450,000 | 450,000 | - | - | Employee Stock Option (right to buy) | |
| Nurix Therapeutics Inc | Arthur Sands T. | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 800,000 | 800,000 | - | - | Employee Stock Option (right to buy) | |
| Nurix Therapeutics Inc | Arthur T. Sands | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2023 | 448,000 | 448,000 | - | - | Employee Stock Option (right to buy) | |
| Nurix Therapeutics Inc | Arthur T. Sands | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 400,000 | 400,000 | - | - | Employee Stock Option (right to buy) | |
| Nurix Therapeutics Inc | Arthur T. Sands | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2022 | 300,000 | 300,000 | - | - | Employee Stock Option (right to buy) | |
| Nurix Therapeutics Inc | Arthur T. Sands | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 150,000 | 150,000 | - | - | Employee Stock Option (right to buy) | |
| Nurix Therapeutics Inc | Arthur T. Sands | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Oct 2020 | 804,170 | 804,170 | - | - | Stock Option (right to buy) |